Summary of Key Information:

Reporting Period (Quarter/Year): Not Specified

Nature of Filing / Announcement: Outcome of Board Meeting under Regulation 30 of SEBI Listing Regulations

Audit Opinion:

Not Specified

Key Financial Highlights:

Not Specified

Standalone Results:

Not Specified

Consolidated Results:

Not Specified

Segment-wise Performance:

Not Specified

Corporate Actions:

Investment in Fabtech Technologies LLC:

  • Investment type: Overseas Direct Investment
  • Target entity: Fabtech Technologies LLC (Wholly-Owned Subsidiary)
  • Total value: AED 1,00,000 (up to ₹24,00,00,000/- at assumed exchange rate of Rs. 26.25)
  • Financial status of subsidiary (as on 31st March 2026):
  • Turnover: NIL
  • Net Loss: AED 1,19,226
  • Networth: (AED 79,325)
  • Industry: Engineering, Procurement, and Construction (EPC)
  • Purpose: Strengthen market position, expand business operations, achieve operational synergies
  • Timeline: Expected completion within one year
  • Related party transaction: Yes, but exempt under Regulation 23(5) of SEBI Listing Regulations

Investment in FT Institutions Private Limited:

  • Target entity: FT Institutions Private Limited (Wholly-Owned Subsidiary)
  • Total value: Rs. 1.00 Lakhs (consideration: Rs. 2,49,00,000/-)
  • Financial status of subsidiary (for year ended 31st March 2026):
  • Turnover: Rs. 1,261.56 Lakhs
  • Net Profit: Rs. 37.82 Lakhs
  • Networth: Rs. 2.21 Lakhs
  • Historical turnover:
  • FY 2025-26: Rs. 1,261.56 Lakhs
  • FY 2024-25: Rs. 697.06 Lakhs
  • FY 2023-24: Rs. 49.18 Lakhs
  • Industry: Pharmaceutical, Biotech and Healthcare
  • Purpose: Strengthen market position, expand business operations, achieve operational synergies
  • Timeline: Expected completion within one month
  • Consideration: 100% cash subscription at face value per share
  • Related party transaction: Yes, but exempt under Regulation 23(5) of SEBI Listing Regulations

Borrowing Limits:

  • Board approved increase in borrowing limits of the Company
  • Remains within overall limits prescribed under Section 180(1)(c) of Companies Act, 2013
  • No shareholder approval required

Director Changes:

  • Mr. Shyam Nagorao Khante (DIN: 06918122) completed tenure as Non-Executive, Independent Director
  • Ceased to be director effective end of business hours on June 25, 2026

Committee Reconstitution:

  • Audit Committee, Nomination and Remuneration Committee, and Corporate Social Responsibility Committee reconstituted effective June 26, 2026
  • Audit Committee composition:
  • Chairperson: Naushad Alimohmed Panjwani (Independent Director)
  • Members: Rupal Dhiren Haria (Independent Director), Bharti Khanna (Independent Director), Chirag Himatlal Doshi (Non-Executive Director)
  • Nomination and Remuneration Committee composition:
  • Chairperson: Rupal Dhiren Haria (Independent Director)
  • Members: Bharti Khanna (Independent Director), Naushad Alimohmed Panjwani (Independent Director), Chirag Himatlal Doshi (Non-Executive Director)

Other Significant Information:

  • All transactions with wholly-owned subsidiaries are on arms' length basis
  • Promoter/promoter group/group companies have no interest in the subsidiaries except through the Company
  • No governmental or regulatory approvals required for the acquisitions